medication
Therapeutic Teams
Tx Archai
Tx Archai helps drug development teams move from biological rationale and fragmented evidence to biomarker-informed clinical strategy.
Primary users
Pharma translational, biomarker, and clinical trial teams.
Supports
- Biomarker strategy and translational planning
- Biomarker-based clinical trial planning
- Patient enrichment and Phase I-III decision support
- Assay and cutoff feasibility
troubleshoot
Diagnostic Teams
Dx Archai
Dx Archai helps diagnostics and assay teams translate testing capabilities, assay evidence, and biomarker data into pharma-facing strategy and partnership value.
Primary users
Diagnostics, assay planning, and biopharma partnership teams.
Supports
- Diagnostic and assay strategy
- Internal testing data intelligence
- CDx / IVD planning and vendor landscape
- Trial support and diagnostic feasibility
insights
Evidence Teams
Evidence Archai
Evidence Archai helps teams transform biomarker, trial, label, publication, RWE, and access evidence into stakeholder-ready strategies.
Primary users
Medical Affairs, HEOR, RWE, and evidence generation teams.
Supports
- Clinical utility and value evidence
- KOL and advisory board preparation
- RWE study concepts and access gaps
- Post-launch evidence strategy